GENova is a biotechnological drug development company with a strict focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings. Each and every product candidate targets problem areas with considerable unmet need and ditto market potential. Subsequent inexpensive value-addition benefits both patients and stakeholders. Fully... 

This Monday morning, 35 minutes into the trading day the major markets are all in the red. The Dow is down -45.42, NASDAQ down -7.49 and S&P 500 down -4.89. On a brighter note those of you trading in the OTC market that own Genova Biotherapeutics, Inc. (GVBP) should be happy to see your stock is up over 30% so far this morning.  Read More →

Things were looking up for the week but have turning south. As of 1:30 pm EST Dow -31.66 NASDAQ -5.31 S&P 500 -2 There is still time for thing to turn but….. The OTC Market has a nice winner today: Genova Biotherapeutics, Inc. (GVBP) currently up over 40% on 47,886,028 in volume.  Read More →